Results 241 to 250 of about 30,396,780 (392)
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Pain and high-impact pain in community-dwelling older adults in Australia and relation to sociodemographic and health-related factors, including physical disability, psychological distress, and quality of life. [PDF]
Joshy G +6 more
europepmc +1 more source
An Evaluation of the Impact of Weston Park Cancer Support Centre [PDF]
Dayson, Christopher +2 more
core +1 more source
Psychosocial impact of COVID-19
S. Dubey +7 more
semanticscholar +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Co-benefits and trade-offs between environmental impact and diet quality: insights from observational dietary data in a Swedish population. [PDF]
Hallström E +4 more
europepmc +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source
Estimating actual striking forces using attenuation properties of Taekwondo protectors. [PDF]
Chae M +5 more
europepmc +1 more source

